Secondary searches were performed using Google Scholar and regulatory sources, e.g., US Food and Drug Administration (FDA) labels and European Medicines Agency (EMA) reports, to capture gray literature and pharmacovigilance data
The effects are quite significant
New alert for GLP-1 agonist shortages Supply of most GLP-1 agonists will continue to be constrained until at least the end of 2024, prescribers have been warned, as a result of increased demand for 'licensed and off-label indications'
This is important for healthcare providers and patients to know their treatment plan
What side effects are common with Ozempic
After you submit your insurance details, Found will contact your insurance company and send back a personalized report showing which medications are covered, whether prior authorization is required, and what your estimated copay will be